Abstract LB-138: Efficacy data of GDC-0449, a systemic Hedgehog pathway antagonist, in a first-in-human, first-in-class Phase I study with locally advanced, multifocal or metastatic basal cell carcinoma patients
Keyword(s):
Phase I
◽
2017 ◽
Vol 23
(4)
◽
pp. 655-659
◽
Keyword(s):
2018 ◽
Vol 79
(3)
◽
pp. AB294
Keyword(s):
Keyword(s):
2021 ◽
Vol 85
(3)
◽
pp. AB89
2017 ◽
Vol 32
(3)
◽
pp. 372-381
◽
2017 ◽
Vol 27
(4)
◽
pp. 386-392
◽
2009 ◽
2014 ◽
Vol 5
(4)
◽